The Clinical and Laboratory Team at Sysmex Inostics spearheads the integration of SafeSEQ NGS technology for highly sensitive detection of clinically relevant mutations in ctDNA. This team is responsible for the operational aspects of the CLIA-certified laboratory services, developing and validating custom assays, and ensuring the delivery of reliable molecular data. Through their work, they support BioPharma partners in selecting real-time therapies, monitoring tumor responses, and detecting minimal residual disease (MRD).
View all